Reason for request
Reassessment of the IAB.
Clinical Benefit
| Substantial |
Le service médical rendu par ces spécialités reste important.
|
Clinical Added Value
| minor |
la Commission maintient l'ASMR IV attribuée le 2 juin 2004 à RISPERDALCONSTA en tant que modalité d'administration susceptible d'améliorer la prise en charge de ces patients.
|
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
SS521rDAzg09GT5y
